May 10, 2019
Rose
Health Care, The Health Care Blog
No comments
Related Posts:
Equipoise and Its Problems By MICHEL ACCAD, MD I recently participated in a debate opposing me to Professor Adam Cifu on the topic of “Evidence-based medicine in the age of COVID.” The debate took place on an episode of Dr. Chadi Nabhan’s Outsp… Read More
Health in 2 Point 00, Episode 132 | Accolade IPO, Somatus, NexHealth, Tatch & moreToday on Health in 2 Point 00, Jess and I cover some big news! Accolade has filed its IPO, so on Episode 132 I give my take on this health care navigation service. We also cover Somatus getting $64 million for chronic kidney … Read More
Goodbye Glasses, Hello SmartglassesBy KIM BELLARD It’s been a few months since I last wrote about augmented reality (AR), and, if anything, AR activity has only picked up since then — particularly in regard to smartglasses. I pointed out the… Read More
THCB Gang Episode 17, LIVE 7/9 1PM PT/4PM ET Episode 17 of “The THCB Gang” will be live-streamed on Thursday, July 9th! Tune in below! Joining me tomorrow are some of our regulars: patient advocate Grace Cordovano (@GraceCordovano), health economist Jane Sarasohn-Kah… Read More
Health in 2 Point 00, Episode 133 | PBMs galore, Genome Medical, & the FCC’s Rural Health ProgramEpisode 133 of Health in 2 Point 00 is brought to you by the letter P — that’s P for PBMs, of course. In this episode, Jess and I talk about Genome Medical extending their series B and getting another $14 million on top of th… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment